Partners' Directory

  Home   Search   Join the Partnership   Login

Contact General Specializations in Countries Contribution to the Global Plan Declaration

View this partner's profile

Organization Contact Information

Name: All India Institute of Medical Sciences
Street 1: Ansari Nagar
Street 2:
City: New Delhi
Province: Delhi
Post Code: 110029
Country: India
Phone: +91 11 2658 8484
Email: sarman_singh@yahoo.com, info@abhas.org
Web Site: http://www.aiims.edu, http://www.drsarmansingh.com

Focal Point Contact Information

Salutation: Prof.
First Name: Sarman
Last Name: Singh
Title: Head, Division of Clinical Microbiology & Molecular Medicine
Email: sarman_singh@yahoo.com
Phone: +91-11-26588484

Alternate Focal Point Contact Information

Salutation: Mr.
First Name: Parveen
Last Name: Kumar
Title: Research Scholar
Email: parveenmicro02@gmail.com
Phone: +91-11-26594977

General Information

Board Constituency: Technical agencies
Organization Type - Primary: Governmental Organization
Organization Type - Secondary: None
Is your organization legally registered in your country: Yes
Organization Reach: International
Organization Description:
An autonomous academic and research organization which also provided tertiary health care to the region. The Focal Contact person is senior Professor Involved in tuberculosis diagnostics and molecular epidemiology of TB, specially HIV-TB coinfection and XDR-TB. Ideal place to develop collaborative projects.
 
Total number of staff in your organization: 100 +
Number of full-time staff who are directly involved with TB: 11 - 25
Number of part-time staff who are directly involved with TB: 0
Number of volunteers who are directly involved with TB: 6 - 10
 
What is your organization's annual budget (USD) dedicated to TB? $100,001-$500,000
How did you hear about the Stop TB Partnership: Stop TB communications
If you were informed or referred by another partner of the Stop TB Partnership please tell us who:
Why do you wish join the Stop TB Partnership: Involvement in Stop TB Working Groups
 
Are you a member of a Stop TB national partnership: India
Are you in contact with your national TB programme: Yes
Please tell us how your organization is contributing to your country's national TB control plan:
Our Laboratory is a training center for Asia region for MODS, NRA, CRI and other non-commercial tests funded by WHO/STOP-TB and also an Intermediary Reference Laboratory (IRL) of India Tb programme.
 

Geographical Reach

Which country is your headquarters located in: India
Which WHO region is the main focus of your work: South East Asian
Which countries do you do operate in:
(This includes countries you are conducting activities in)
India

Specializations

Advocacy
Delivery of health services and care
Provision of drugs, diagnostics and commodities
Research and Development
Technical Assistance

Specializations in Countries

Delivery of health services and care India

Contribution

Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below:

TB Care Delivery:
We are partner in the India Government's TB control programme.

Drug-Resistant TB:
We conduct research ( clinical, epidemiological, diagnostic) to map the emergence of MDR-TB and diagnostic methods.

TB-HIV:
Our major focus is to control or minimse the MDR/XDR TB epidemic in Persons living with HIV, using various diagnostic and advocacy tools.

Laboratory Strengthening:
We are string advocates for laboratory strenghening and feel that in TB endemic countries this should be the top priority for all TB control efforts.

New Diagnostics:
We have patented some of novel molecular and proteomic products for rapid and accurate diagnosis of TB and drug resistance prediction.

New TB Drugs:
We evaluate various compounds for their efficacy against Mycobacterial species, in-vito, ex-vivo, and in-vivo

Fundamental Research:
Our group carries fundamental research for improved diagnosis, therapy and control of TB

Research:
We help the national Tb control programs such PMTD and evaluation of new diagnostics etc.

Declaration

Declaration of interests:
None

Application date:  
Last updated: June 17, 2014